@article{30ac5da8850f473d9b373240d03b3f65,
title = "Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy",
author = "Hiromasa Yamamoto and Yosuke Togashi",
note = "Funding Information: Disclosure: Dr. Togashi reports receiving research grants and honoraria from Ono Pharmaceutical and Bristol Myers Squibb; research grants from Daiichi Sankyo, Kotai Biotechnologies, and KORTUC; and honoraria from Chugai Pharmaceutical and Merck Sharp \& Dohme , outside of this study. Dr. Yamamoto declares no conflict of interest. ",
year = "2022",
month = jan,
doi = "10.1016/j.jtho.2021.10.019",
language = "English",
volume = "17",
pages = "10--12",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Elsevier Inc.",
number = "1",
}